Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in Arch Bronconeumol

Retrieve available abstracts of 102 articles:
HTML format



Single Articles


    June 2022
  1. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    PubMed    


  2. LONG MB, Chalmers JD
    Treating Neutrophilic Inflammation in Airways Diseases.
    Arch Bronconeumol. 2022;58:463-465.
    PubMed    


  3. MANISCALCO M, Fuschillo S, Ambrosino P, D'Anna SE, et al
    Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients.
    Arch Bronconeumol. 2022;58:517-519.
    PubMed    


  4. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
    The 7 Cardinal Sins of COPD in Spain.
    Arch Bronconeumol. 2022;58:498-503.
    PubMed     Abstract available


  5. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    Arch Bronconeumol. 2022;58:482-489.
    PubMed     Abstract available


  6. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
    Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
    Arch Bronconeumol. 2022;58:474-481.
    PubMed     Abstract available


    May 2022
  7. PASCUAL S, Dorado S, Urrutia I
    Physical Activity and Asthma.
    Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
    PubMed    


  8. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
    Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
    Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.
    PubMed    


  9. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
    [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
    Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
    PubMed    


  10. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    [Translated article] Asthma Also Exists in Older People.
    Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
    PubMed    


  11. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:T451-T453.
    PubMed    


  12. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:412-417.
    PubMed     Abstract available


  13. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    [Translated article] Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:T433.
    PubMed    


  14. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:T412-T417.
    PubMed     Abstract available


  15. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
    [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
    Arch Bronconeumol. 2022;58:T425-T426.
    PubMed    


  16. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:T386-T387.
    PubMed    


  17. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:T454-T456.
    PubMed    


  18. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:442-443.
    PubMed    


  19. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:433.
    PubMed    


  20. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:386-387.
    PubMed    


  21. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:T442-T443.
    PubMed    


  22. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:454-456.
    PubMed    


  23. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:451-453.
    PubMed    


    April 2022
  24. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
    High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
    Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
    PubMed    


  25. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
    Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Arch Bronconeumol. 2022;58 Suppl 1:39-50.
    PubMed     Abstract available


  26. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    [Translated article] The ANTES Program in COPD: First Year.
    Arch Bronconeumol. 2022;58:T291-T294.
    PubMed    


  27. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
    Arch Bronconeumol. 2022;58:T364-T366.
    PubMed    


  28. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:334-344.
    PubMed     Abstract available


  29. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
    A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
    Arch Bronconeumol. 2022;58:363.
    PubMed    


  30. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
    Arch Bronconeumol. 2022;58:364-366.
    PubMed    


  31. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:345-351.
    PubMed     Abstract available


  32. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    The ANTES program in COPD: First year.
    Arch Bronconeumol. 2022;58:291-294.
    PubMed    


  33. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:T345-T351.
    PubMed     Abstract available


  34. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    [Translated article] Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:T323-T333.
    PubMed     Abstract available


  35. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:323-333.
    PubMed     Abstract available


  36. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:T334-T344.
    PubMed     Abstract available


    March 2022
  37. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    Asthma also exists in older people.
    Arch Bronconeumol. 2022 Mar 11. pii: S0300-2896(22)00183.
    PubMed    


    February 2022
  38. MARTINEZ-GONZALEZ C, Adanez Garcia J, Blanco I
    Term pregnancy of a patient with severe pulmonary emphysema associated with (PI*ZZ) alpha-1 antitrypsin.
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00094.
    PubMed    


  39. BARALDI F, Alfano F, Contoli M, Papi A, et al
    Small Airway Disease in Asthma: Why is it so Important?
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00093.
    PubMed    


  40. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    PubMed     Abstract available


  41. CAZZOLA M, Rogliani P, Matera MG
    The Future of Bronchodilators in COPD and Asthma.
    Arch Bronconeumol. 2022;58:107-108.
    PubMed    


    January 2022
  42. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
    Arch Bronconeumol. 2022;58:35-51.
    PubMed     Abstract available


    December 2021
  43. MARTINEZ-GARCIA MA, Aksamit TR, Aliberti S
    Bronchiectasis as a Long-Term Consequence of SARS-COVID-19 Pneumonia: Future Studies are Needed.
    Arch Bronconeumol. 2021;57:739-740.
    PubMed    


  44. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
    Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
    Arch Bronconeumol. 2021;57:774-776.
    PubMed    


  45. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
    Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
    Arch Bronconeumol. 2021;57:741-749.
    PubMed     Abstract available


  46. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021;57:731-732.
    PubMed    


    November 2021
  47. OJANGUREN I, Satia I, Usmani OS
    The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future.
    Arch Bronconeumol. 2021 Nov 1. pii: S0300-2896(21)00350.
    PubMed    


  48. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
    Plastic bronchitis and Noonan syndrome.
    Arch Bronconeumol. 2021;57:705.
    PubMed    


  49. FERREIRO A, Granados G, Villar A
    Peribronchovascular emphysema. The Macklin effect.
    Arch Bronconeumol. 2021;57:697.
    PubMed    


  50. DE-TORRES JP, Wisnivesky JP
    Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
    Arch Bronconeumol. 2021;57:679-680.
    PubMed    


  51. MARTINEZ-GARCIA MA
    Bronchiectasis and Eosinophils.
    Arch Bronconeumol. 2021;57:671-672.
    PubMed    


    October 2021
  52. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
    Arch Bronconeumol. 2021;57:662-664.
    PubMed    


  53. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
    Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
    Arch Bronconeumol. 2021;57:630-636.
    PubMed     Abstract available


  54. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021;57:621-622.
    PubMed    


  55. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
    Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
    Arch Bronconeumol. 2021;57:617-620.
    PubMed    


  56. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
    Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
    Arch Bronconeumol. 2021;57:664-666.
    PubMed    


    September 2021
  57. ALCARAZ-SERRANO V, Lee AL, Gimeno-Santos E
    Respiratory Physiotherapy and Bronchiectasis.
    Arch Bronconeumol. 2021 Sep 14. pii: S0300-2896(21)00316.
    PubMed    


  58. BLANCO-CONDE S, Gonzalez-Cortes C, Lopez-Medrano R, Carazo-Fernandez L, et al
    Mycobacterium abscessus Infected Neutrophils as an In Vitro Model for Bronchiectasis. Neutrophils Prevent Mycobacterial Aggregation.
    Arch Bronconeumol. 2021 Sep 4. pii: S0300-2896(21)00231.
    PubMed    


  59. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D supplementation: A treatment with possible benefits in asthma.
    Arch Bronconeumol. 2021;57:567-568.
    PubMed    


  60. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
    Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
    Arch Bronconeumol. 2021;57:614-615.
    PubMed    


  61. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
    Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
    Arch Bronconeumol. 2021;57:593-594.
    PubMed    


  62. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
    Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
    Arch Bronconeumol. 2021;57:577-583.
    PubMed     Abstract available


  63. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
    Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
    Arch Bronconeumol. 2021;57:604-605.
    PubMed    


  64. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
    Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
    Arch Bronconeumol. 2021;57:596-599.
    PubMed    


    August 2021
  65. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
    Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Arch Bronconeumol. 2021;57:533-539.
    PubMed     Abstract available


  66. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
    Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
    Arch Bronconeumol. 2021;57:528-532.
    PubMed     Abstract available


  67. GARCIA-SANZ MT, Gonzalez-Barcala FJ
    COPD is more than just lung function: Let's not forget depression.
    Arch Bronconeumol. 2021;57:519-520.
    PubMed    


    July 2021
  68. MCDONALD VM, Gibson PG
    Treatable Traits in Asthma and COPD.
    Arch Bronconeumol. 2021 Jul 16. pii: S0300-2896(21)00206.
    PubMed    


  69. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
    Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
    Arch Bronconeumol. 2021;57:464-470.
    PubMed     Abstract available


    June 2021
  70. MARCHIORI E, Souza Rodrigues R, Menna Barreto M
    Exuberant Paraseptal Emphysema Associated With Pulmonary Alveolar Microlithiasis: 12 Years of Evolution.
    Arch Bronconeumol. 2021 Jun 24. pii: S0300-2896(21)00196.
    PubMed    


  71. HERRERO MARTIN S, Hueto Perez de Heredia J, Cuesta Remon A, Gomez Fernandez M, et al
    Is a mobile application useful for patients with moderate-severe asthma?
    Arch Bronconeumol. 2021 Jun 16. pii: S1579-2129(21)00188.
    PubMed    


  72. BLANCO-APARICIO M, Calvo-Alvarez U, Gonzalez-Barcala FJ
    Biologics in Asthma: Don't Let the Magic Bullets Sink the Boat.
    Arch Bronconeumol. 2021;57:383-384.
    PubMed    


  73. CABRERA LOPEZ C, Gomez Saenz JT, Molina Paris J, Trigueros Carrero JA, et al
    Enabling a Community Approach to Respiratory Diseases: The HACER COPD Project.
    Arch Bronconeumol. 2021;57:442-444.
    PubMed    


  74. GALERA R, Casitas R, Martinez-Ceron E, Rodriguez-Fraga O, et al
    Effect of Dynamic Hyperinflation on Cardiac Response to Exercise of Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2021;57:406-414.
    PubMed     Abstract available


  75. CABRERA LOPEZ C, Gomez Saenz JT, Molina Paris J, Trigueros Carrero JA, et al
    Enabling a Community Approach to Respiratory Diseases: The HACER COPD project.
    Arch Bronconeumol. 2021;57:442-444.
    PubMed    


  76. GALERA R, Casitas R, Martinez-Ceron E, Rodriguez-Fraga O, et al
    Effect of Dynamic Hyperinflation on Cardiac Response to Exercise of Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2021;57:406-414.
    PubMed     Abstract available


    May 2021
  77. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.
    Arch Bronconeumol. 2021 May 26. pii: S0300-2896(21)00165.
    PubMed     Abstract available


    April 2021
  78. SAWAMURA MVY, Athanazio RA, Nucci MCNTM, Rached SZ, et al
    Automated Computed Tomography Lung Densitometry in Bronchiectasis Patients.
    Arch Bronconeumol. 2021 Apr 25. pii: S0300-2896(21)00136.
    PubMed    


    March 2021
  79. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021 Mar 11. pii: S0300-2896(21)00094.
    PubMed    


  80. HALPIN DMG, Vogelmeier CF, Agusti AA
    COPD & COVID-19.
    Arch Bronconeumol. 2021;57:162-164.
    PubMed    


  81. SORIANO JB
    Reply to <>.
    Arch Bronconeumol. 2021;57:235.
    PubMed    


  82. LOPEZ-CAMPOS JL, Alcazar Navarrete B
    COPD Diagnosis in EPI-SCAN II.
    Arch Bronconeumol. 2021;57:234.
    PubMed    


    February 2021
  83. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021 Feb 17. pii: S0300-2896(21)00054.
    PubMed    


    January 2021
  84. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D Supplementation: A Treatment With Possible Benefits in Asthma.
    Arch Bronconeumol. 2021 Jan 28. pii: S0300-2896(21)00027.
    PubMed    


  85. GARCIA CLEMENTE M, Madrid Carbajal C, Iscar Urrutia M
    Influenza, SARS-CoV-2 and Invasive Pulmonary Aspergillosis.
    Arch Bronconeumol. 2021;57 Suppl 1:11-12.
    PubMed    


  86. SALES AR, Casagrande EM, Hochhegger B, Zanetti G, et al
    The Reversed Halo Sign and COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging Finding.
    Arch Bronconeumol. 2021;57 Suppl 1:73-75.
    PubMed    


  87. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    [Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
    Arch Bronconeumol. 2021;57:13-14.
    PubMed    


    December 2020
  88. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged Treatment With Inhaled Ampicillin in Children With Non-cystic Fibrosis Bronchiectasis.
    Arch Bronconeumol. 2020 Dec 25. pii: S0300-2896(20)30538.
    PubMed    


  89. HERRERO MARTIN S, Hueto Perez de Heredia J, Cuesta Remon A, Gomez Fernandez M, et al
    Is a Mobile Application Useful for Patients with Moderate-Severe Asthma?
    Arch Bronconeumol. 2020 Dec 10. pii: S0300-2896(20)30529.
    PubMed    


  90. FERNANDEZ-GARCIA S, Represas-Represas C, Ruano-Ravina A, Fernandez Villar A, et al
    Reply to "The Importance of Dependence in Global Assessment of Hospitalized Patient".
    Arch Bronconeumol. 2020;56:834-835.
    PubMed    


  91. BRIONGOS-FIGUERO LS, Cobos Siles M, Gabella Martin M, Abadia Otero J, et al
    The Importance of Dependence in Global Assessment of Hospitalized Patient.
    Arch Bronconeumol. 2020;56:833-834.
    PubMed    


    November 2020
  92. POSSO M, Comas M, Roman M, Domingo L, et al
    Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
    Arch Bronconeumol. 2020;56:756-758.
    PubMed    


    October 2020
  93. PLAZA V, Blanco M, Garcia G, Korta J, et al
    Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0.
    Arch Bronconeumol. 2020 Oct 22. pii: S0300-2896(20)30383.
    PubMed    


  94. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19.
    Arch Bronconeumol. 2020 Oct 22. pii: S0300-2896(20)30385.
    PubMed    


    September 2020
  95. BLANCO-APARICIO M, Calvo-Alvarez U, Gonzalez-Barcala FJ
    Biologics in Asthma: Don't Let the Magic Bullets Sink the Boat.
    Arch Bronconeumol. 2020 Sep 30. pii: S0300-2896(20)30302.
    PubMed    


  96. TANG J, Ramis-Cabrer D, Curull V, Mateu-Jimenez M, et al
    Markers of Stroma in Lung Cancer: Influence of COPD.
    Arch Bronconeumol. 2020 Sep 24. pii: S0300-2896(20)30311.
    PubMed     Abstract available


  97. LOZANO J, Nafria B, Alsina L
    The Long Road to Biologic Therapies for Asthma in Pediatric Patients.
    Arch Bronconeumol. 2020 Sep 23. pii: S0300-2896(20)30282.
    PubMed    


    July 2020
  98. PLAZA MORAL V, Gomez-Outes A, Quirce Gancedo S, Alobid I, et al
    Discrepancies Between GEMA and GINA in the Classification of Inhaled Corticosteroids.
    Arch Bronconeumol. 2020;56:472-473.
    PubMed    


    May 2020
  99. DE-TORRES JP, Wisnivesky JP, Bastarrika G, Wilson DO, et al
    Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
    Arch Bronconeumol. 2020 May 12. pii: S0300-2896(20)30104.
    PubMed     Abstract available


    February 2020
  100. MUNOZ-LUCAS MA, Jareno-Esteban J, Gutierrez-Ortega C, Lopez-Guijarro P, et al
    Influence of Chronic Obstructive Pulmonary Disease on Volatile Organic Compounds in Patients with Non-small Cell Lung Cancer.
    Arch Bronconeumol. 2020 Feb 10. pii: S0300-2896(20)30006.
    PubMed     Abstract available


    November 2019
  101. BLANCO I, Valeiro B, Torres-Castro R, Barberan-Garcia A, et al
    Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2019 Nov 23. pii: S0300-2896(19)30407.
    PubMed     Abstract available


    March 2019
  102. SEIJO LM, Peces-Barba G
    Inhaled Corticosteroids and Lung Cancer in COPD.
    Arch Bronconeumol. 2019 Mar 2. pii: S0300-2896(19)30068.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: